Ruiping Guo

机构：United States Nuclear Regulatory Commission, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking University, Peking University Third Hospital · ORCID：0000-0002-9349-5983

发表论文 7 篇 · 总被引 38 次 · h-index 2

代表论文

• AMPK Attenuation of β-Adrenergic Receptor-Induced Cardiac Injury via Phosphorylation of β-Arrestin-1-ser330 (2024 · Circulation Research · 被引 29)
• [Application of immunohistochemical staining of PRAME in differential diagnosis between melanoma and melanocytic nevus]. (2022 · PubMed · 被引 3)
• Lipid Nanoparticle (LNP) ‐A Vector Suitable for Evolving Therapies for Advanced Hepatocellular Carcinoma (HCC) (2024 · Global Challenges · 被引 2)
• CDK4 gene copy number increase and concurrent genetic changes in acral melanoma of a Chinese cohort (2024 · Pathology · 被引 2)
• [Copy number variations of CCND1 gene and chromosome 11 centromere in acral melanoma]. (2024 · PubMed)
• [Advance on cyclin D1 and CDK4 in cutaneous melanoma]. (2023 · PubMed)